Sigma‐1 receptor chaperones regulate the secretion of brain‐derived neurotrophic factor
Open accessThe DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
The sigma‐1 receptor (Sig‐1R) is a novel endoplasmic reticulum (ER) molecular chaperone that regulates protein folding and degradation. The Sig‐1R activation by agonists is known to improve memory, promote cell survival, and exert an antidepressant‐like action in animals. Cutamesine (SA4503), a selective Sig‐1R ligand, was shown to increase BDNF in the hippocampus of rats. How exactly the intracellular chaperone Sig‐1R or associated ligand causes the increase of BDNF or any other neurotrophins is unknown. We examined here whether the action of Sig‐1Rs may relate to the post‐translational processing and release of BDNF in neuroblastoma cell lines. We used in vitro assays and confirmed that cutamesine possesses the bona fide Sig‐1R agonist property by causing the dissociation of BiP from Sig‐1Rs. The C‐terminus of Sig‐1Rs exerted robust chaperone activity by completely blocking the aggregation of BDNF and GDNF in vitro. Chronic treatment with cutamesine in rat B104 neuroblastoma caused a time‐ and dose‐dependent potentiation of the secretion of BDNF without affecting the mRNA level of BDNF. Cutamesine decreased the intracellular level of pro‐BDNF and mature BDNF whereas increased the extracellular level of mature BDNF. The pulse‐chase experiment indicated that the knockdown of Sig‐1Rs decreased the secreted mature BDNF in B104 cells without affecting the synthesis of BDNF. Our findings indicate that, in contrast to clinically used antidepressants that promote the transcriptional upregulation of BDNF, the Sig‐1R agonist cutamesine potentiates the post‐translational processing of neurotrophins. This unique pharmacological profile may provide a novel therapeutic opportunity for the treatment of neuropsychiatric disorders. Synapse, 2012. © 2012 Wiley Periodicals, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hayashi, T., & Su, T.-P. (2007) · Cell · doi:10.1016/j.cell.2007.08.036 · Cited by 1,826 · cited 10×
“The expression vectors for enhanced yellow fluorescent protein (EYFP)-tagged Sig-1Rs were constructed by ligating mouse Sig-1R cDNA in the pEYFP-N1 vector (Hayashi and Su, 2007).”
BackgroundMethodInfluentialSelf-citationRegulation of Cell Survival by Secreted Proneurotrophins
Lee, R., Kermani, P., Teng, K. K., & Hempstead, B. L. (2001) · Science · doi:10.1126/science.1065057 · Cited by 1,670
The yin and yang of neurotrophin action
Lu, B., Pang, P. T., & Woo, N. H. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1726 · Cited by 1,356
Sen, S., Duman, R., & Sanacora, G. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.05.005 · Cited by 1,232
New insights into BDNF function in depression and anxiety
Martinowich, K., Manji, H., & Lu, B. (2007) · Nature Neuroscience · doi:10.1038/nn1971 · Cited by 1,221 · cited 2×
“In fact, clinically used antidepressants activate transcription of BDNF mRNA partly via their action on the monoaminergic systems (MacQueen et al., 2001; Martinowich et al., 2007; Saarelainen et al., 2003).”
Shimizu, E., Hashimoto, K., Okamura, N., Koike, K., Komatsu, N., Kumakiri, C., Nakazato, M., Watanabe, H., Shinoda, N., Okada, S.-I., et al. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00181-1 · Cited by 1,151 · cited 1×
“Expression of BDNF is tightly regulated at the transcriptional level (Brunoni et al., 2008; Calabrese et al., 2010; Racagni and Popoli 2008; Sen et al., 2008; Shimizu et al., 2003; Yasui-Furukori et al., 2011).”
Figurov, A., Pozzo-Miller, L. D., Olafsson, P., Wang, T., & Lu, B. (1996) · Nature · doi:10.1038/381706a0 · Cited by 1,106 · cited 1×
“…apoptosis via the pan-neurotrophin receptor p75NTR, whereas mature BDNF promotes cell survival and LTP via the Trk receptor tyrosine kinases) (Figurov et al., 1996), the post-translational processes promoting the cleavage of pro-BDNF or the secretion of mature BDNF may represent another…”
Brunoni, A. R., Lopes, M., & Fregni, F. (2008) · International Journal of Neuropsychopharmacology · doi:10.1017/s1461145708009309 · Cited by 972
BDNF and Activity-Dependent Synaptic Modulation: Figure 1.
Lu, B. (2003) · Learning & Memory · doi:10.1101/lm.54603 · Cited by 945
Saarelainen, T., Hendolin, P., Lucas, G., Koponen, E., Sairanen, M., MacDonald, E., Agerman, K., Haapasalo, A., Nawa, H., Aloyz, R., et al. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-01-00349.2003 · Cited by 800
The pharmacology of sigma-1 receptors.
Maurice, T., & Su, T.-P. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.07.001 · Cited by 654
Self-citationCellular and molecular mechanisms in the long-term action of antidepressants.
Racagni, G., & Popoli, M. (2008) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2008.10.4/gracagni · Cited by 192 · cited 1×
“Expression of BDNF is tightly regulated at the transcriptional level (Brunoni et al., 2008; Calabrese et al., 2010; Racagni and Popoli 2008; Sen et al., 2008; Shimizu et al., 2003; Yasui-Furukori et al., 2011).”
Yagasaki, Y., Numakawa, T., Kumamaru, E., Hayashi, T., Su, T.-P., & Kunugi, H. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m508157200 · Cited by 122 · cited 2×
“Sig1Rs potentiate BDNF-induced activation of the PLCgamma/IP3/Ca 21 pathway that results in the glutamate release from cortical neurons (Yagasaki et al., 2006).”
Self-citation
Cited by
The Sigma-1 Receptor as a Pluripotent Modulator in Living Systems
Su, T.-P., Su, T.-C., Nakamura, Y., & Tsai, S.-Y. (2016) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2016.01.003 · Cited by 320
Self-citationPsychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms
Inserra, A., De Gregorio, D., & Gobbi, G. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000056 · Cited by 232
Dextromethorphan: An update on its utility for neurological and neuropsychiatric disorders
Nguyen, L., Thomas, K. L., Lucke-Wold, B. P., Cavendish, J. Z., Crowe, M. S., & Matsumoto, R. R. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.01.016 · Cited by 141
Inserra, A. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00330 · Cited by 91
“SIGMAR1 is a transmembrane protein with neuroprotective, neurotrophic, and immunomodulatory properties found in high concentrations in limbic areas of the human brain and in immune cells (Ishikawa et al., 2007; Fujimoto et al., 2012; Frecska et al., 2013; Szabo et al., 2014).”
BackgroundInfluentialWang, Y., Ni, J., Gao, T., Gao, C., Guo, L., & Yin, X. (2020) · Glia · doi:10.1002/glia.23850 · Cited by 42
Metadata
- Authors
- Fujimoto, M., Hayashi, T., Urfer, R., Mita, S., & Su, T.
- Venue
- Synapse
- Publisher
- Wiley
- Published
- 2012-03-16
- Volume
- 66
- Issue
- 7
- Pages
- 630-639
- ISSN
- 0887-4476 (ISSN-L)
- 1098-2396
- OpenAlex
- W2003888864
- Cited by
- 126
- References
- 13
- FWCI
- 3.37
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.